⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2026Open Access

Development of a rapid-response platform for Influenza A (H5) virus-like particle production

Leila Sawada Luis Guardalini Durvanei Maria Flávio Lichtenstein Thaissa Bernardino Wagner Quintilio Soraia Jorge

View Full Paper

Ask AI

Bookmark

Share

Key Points

The research aims to create a quick method for producing virus-like particles for Influenza A (H5).
Developed a rapid-response platform for antigen production.
Evaluated the effectiveness of virus-like particle production methods.
Successfully produced virus-like particles for Influenza A (H5).
Demonstrated feasibility of quick vaccine response to potential outbreaks.

Implication

Develops a platform for rapid vaccine production against Influenza A (H5), indicating faster responses to outbreaks.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sawada et al. (2026) studied this question.

synapsesocial.com/papers/6a192c0ffab5b468c4415009 https://doi.org/10.35259/isi.2026_76342

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1In silico design of dengue virus epitopes, recombinant antigens and scfv antibodies for serotype-specific diagnostic developmentOriginal Research · 2026
2Development and functional evaluation of conventional mRNA vaccine candidates against respiratory syncytial virusOriginal Research · 2026
3A cell-based technological proposal for modernization and optimization of the 17DD yellow fever vaccine productionOriginal Research · 2026
4Respiratory syncytial virus vaccine: productive development partnership, regulatory and manufacturing advances, and perspectives for the National Immunization ProgramOriginal Research · 2026
5Development and analytical qualification of a cell-based potency assay for mRNA COVID-19 vaccinesOriginal Research · 2026

Monitoring of the quality of rapid HIV tests and self-tests2026
Bio-Manguinhos and new generation of vaccines: consolidation of mRNA-LNP production and evaluation of critical quality attributes at pilot scale2026
Advancing the multivalent vaccine horizon: development of bicistronic self-amplifying RNA platforms for next-generation immunobiologicals2026